Young, R; Glennon, RA. Cocaine-stimulus generalization to two new designer drugs: Methcathinone and 4-methylaminorex. Pharmacol. Biochem. Behav., 1 May 1993, 45 (1), 209–214. 224 kB. https://doi.org/10.1016/0091-3057(93)90110-F #Aminorex
Woolverton, WL; Massey, BW; Winger, G; Patrick, GA; Harris, LS. Evaluation of the abuse liability of aminorex. Drug Alcohol Depend., 1 Dec 1994, 36 (3), 187–192. 711 kB. https://doi.org/10.1016/0376-8716(94)90144-9
Brandt, SD; Baumann, MH; Partilla, JS; Kavanagh, PV; Power, JD; Talbot, B; Twamley, B; Mahony, O; O’Brien, J; Elliott, SP; Archer, RP; Patrick, J; Singh, K; Dempster, NM; Cosbey, SH. Characterization of a novel and potentially lethal designer drug (±)-cis-para-methyl-4-methylaminorex (4,4′-DMAR, or ‘Serotoni’). Drug Test. Anal., 1 Jul 2014, 6 (7-8), 684-695. 1.1 MB. https://doi.org/10.1002/dta.1668
Hess, C; Ritke, N; Sydow, K; Mehling, L; Ruehs, H; Madea, B; Musshoff, F. Determination of levamisole, aminorex, and pemoline in plasma by means of liquid chromatography-mass spectrometry and application to a pharmacokinetic study of levamisole. Drug Test. Anal., 1 Oct 2014, 6 (10), 1049-1054. 451 kB. https://doi.org/10.1002/dta.1619
McLaughlin, G; Morris, N; Kavanagh, PV; Power, JD; Twamley, B; O’Brien, J; Talbot, B; Dowling, G; Mahony, O; Brandt, SD; Patrick, J; Archer, RP; Partilla, JS; Baumann, MH. Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3′,4′-methylenedioxy-4-methylaminorex (MDMAR). Drug Test. Anal., 1 Jul 2015, 7 (7), 555-564. 517 kB. https://doi.org/10.1002/dta.1732
Calderon, SN; Klein, M. A regulatory perspective on the abuse potential evaluation of novel stimulant drugs in the United States. Neuropharmacology, 1 Dec 2014, 87, 97-103. 266 kB. https://doi.org/10.1016/j.neuropharm.2014.04.001
Helm, K. Synthese und funktionelle In-vitro-Pharmakologie neuer Liganden des 5-HT2A-Rezeptors aus der Klasse. Ph. D. Thesis, Universität Regensburg, Dresden, 1 Jan 2014. 3.2 MB. #14 LC,MS,NMR,IR
Biel, JH; Bopp, BA. Amphetamines: Structure-activity relationships. In Handbook of Psychopharmacology: Stimulants; Iversen, LL; Iversen, SD; Snyder, SH, Eds., Plenum Press, New York, 1 Jan 1978; pp 1–39. 1.0 MB. https://doi.org/10.1007/978-1-4757-0510-2_1
Brewster, ME; Davis, FT. Appearance of aminorex as a designer analog of methylaminorex. J. Forensic Sci., 1 Mar 1991, 36 (2), 587–592. 302 kB. https://doi.org/10.1520/JFS13063J #Aminorex MS,NMR,other
EMCDDA. Report on the risk assessment of 4,4′-DMAR, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Oct 2015. 1.1 MB. #Aminorex MS,NMR
Maier, J; Mayer, FP; Brandt, SD; Sitte, HH. DARK classics in chemical neuroscience: Aminorex analogues. ACS Chem. Neurosci., 17 Oct 2018, 9 (10), 2484–2502. 1.8 MB. https://doi.org/10.1021/acschemneuro.8b00415 #Aminorex
Bork, W; Dahlenburg, R; Gimbel, M; Jacobsen-Bauer, A; Zörntlein, S. Herleitung Von Grenzwerten Der „nicht Geringen Menge“ Im Sinne Des Btmg. Toxichem Krimtech, 1 Jan 2019, 86 (1), 5–91. 4.4 MB. #AP-001